ZA986365B - Novel method of treatment. - Google Patents

Novel method of treatment.

Info

Publication number
ZA986365B
ZA986365B ZA9806365A ZA986365A ZA986365B ZA 986365 B ZA986365 B ZA 986365B ZA 9806365 A ZA9806365 A ZA 9806365A ZA 986365 A ZA986365 A ZA 986365A ZA 986365 B ZA986365 B ZA 986365B
Authority
ZA
South Africa
Prior art keywords
treatment
novel method
novel
Prior art date
Application number
ZA9806365A
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA986365(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA986365B publication Critical patent/ZA986365B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9806365A 1997-07-18 1998-07-17 Novel method of treatment. ZA986365B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ZA986365B true ZA986365B (en) 2000-01-17

Family

ID=10816177

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806365A ZA986365B (en) 1997-07-18 1998-07-17 Novel method of treatment.

Country Status (41)

Country Link
EP (1) EP0998291B2 (xx)
JP (2) JP2001510158A (xx)
KR (1) KR100680667B1 (xx)
CN (1) CN1264302A (xx)
AP (1) AP1318A (xx)
AR (2) AR016768A1 (xx)
AT (1) ATE366577T1 (xx)
AU (1) AU743269B2 (xx)
BG (1) BG64892B1 (xx)
BR (1) BR9810904A (xx)
CA (1) CA2297115C (xx)
CO (1) CO4940422A1 (xx)
CY (1) CY1107745T1 (xx)
CZ (1) CZ302668B6 (xx)
DE (1) DE69838066T3 (xx)
DK (1) DK0998291T4 (xx)
DZ (1) DZ2564A1 (xx)
EA (1) EA003303B1 (xx)
ES (1) ES2290989T5 (xx)
GB (1) GB9715306D0 (xx)
HK (1) HK1029272A1 (xx)
HU (1) HU229119B1 (xx)
ID (1) ID24198A (xx)
IL (1) IL134045A0 (xx)
IN (1) IN189035B (xx)
MA (1) MA26522A1 (xx)
MY (1) MY138246A (xx)
NO (1) NO326356B1 (xx)
NZ (3) NZ520652A (xx)
OA (1) OA11632A (xx)
PE (1) PE99799A1 (xx)
PL (2) PL338127A1 (xx)
PT (1) PT998291E (xx)
SI (1) SI0998291T2 (xx)
SK (2) SK287823B6 (xx)
TR (1) TR200000135T2 (xx)
TW (1) TW586926B (xx)
UA (1) UA70302C2 (xx)
UY (1) UY25103A1 (xx)
WO (1) WO1999003476A1 (xx)
ZA (1) ZA986365B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
AU2004285354B2 (en) 2003-10-31 2009-09-17 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
PE20110019A1 (es) 2005-12-22 2011-01-27 Takeda Pharmaceutical Composicion farmaceutica que contiene un sensibilizante de insulina y un secretagogo de insulina

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
EP0528764B1 (en) * 1991-08-16 1996-06-12 Sandoz Ltd. Inhaler for administration of powdery substances
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
DE69838066T3 (de) 2012-03-29
SI0998291T1 (sl) 2007-12-31
UY25103A1 (es) 2000-12-29
AU8448798A (en) 1999-02-10
NZ520652A (en) 2004-06-25
SK287823B6 (sk) 2011-11-04
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
OA11632A (en) 2004-11-22
IL134045A0 (en) 2001-04-30
JP2005247865A (ja) 2005-09-15
CZ2000173A3 (en) 2001-05-16
EP0998291B1 (en) 2007-07-11
BG104139A (en) 2000-11-30
KR20010021948A (ko) 2001-03-15
EP0998291A1 (en) 2000-05-10
CZ302668B6 (cs) 2011-08-24
AR019331A2 (es) 2002-02-13
NO20000229D0 (no) 2000-01-17
ES2290989T5 (es) 2011-11-11
PL338127A1 (en) 2000-09-25
EA200000141A1 (ru) 2000-08-28
NO326356B1 (no) 2008-11-17
DK0998291T4 (da) 2011-09-26
WO1999003476A1 (en) 1999-01-28
BG64892B1 (bg) 2006-08-31
TR200000135T2 (tr) 2000-05-22
CA2297115C (en) 2010-02-23
ID24198A (id) 2000-07-13
SI0998291T2 (sl) 2011-10-28
MA26522A1 (fr) 2004-12-20
CA2297115A1 (en) 1999-01-28
DZ2564A1 (fr) 2003-02-15
SK602000A3 (en) 2000-07-11
DE69838066D1 (de) 2007-08-23
CY1107745T1 (el) 2013-04-18
EP0998291B2 (en) 2011-07-06
AU743269B2 (en) 2002-01-24
HK1029272A1 (en) 2001-03-30
TW586926B (en) 2004-05-11
ES2290989T3 (es) 2008-02-16
SK288053B6 (sk) 2013-03-01
NZ501256A (en) 2002-09-27
GB9715306D0 (en) 1997-09-24
ATE366577T1 (de) 2007-08-15
IN189035B (xx) 2002-12-07
HU229119B1 (en) 2013-08-28
HUP0003634A3 (en) 2003-04-28
CN1264302A (zh) 2000-08-23
UA70302C2 (uk) 2004-10-15
DK0998291T3 (da) 2007-11-05
AR016768A1 (es) 2001-08-01
PL199125B1 (pl) 2008-08-29
PE99799A1 (es) 1999-12-22
CO4940422A1 (es) 2000-07-24
MY138246A (en) 2009-05-29
NZ515555A (en) 2002-09-27
HUP0003634A2 (hu) 2001-07-30
BR9810904A (pt) 2000-09-26
NO20000229L (no) 2000-01-17
PT998291E (pt) 2007-10-11
AP2000001734A0 (en) 2000-03-31
KR100680667B1 (ko) 2007-02-09
AP1318A (en) 2004-10-22
JP2001510158A (ja) 2001-07-31

Similar Documents

Publication Publication Date Title
ZA200108446B (en) Novel method of treatment.
GB9617780D0 (en) Method of treatment
ZA986363B (en) Novel method of treatment.
ZA985237B (en) Novel method of treatment.
GB9605828D0 (en) Treatment method
GB9707693D0 (en) Novel method of treatment
ZA986364B (en) Novel method of treatment.
ZA986365B (en) Novel method of treatment.
ZA977867B (en) Method of treatment.
GB9714841D0 (en) Treatment method
ZA200007396B (en) Method of treatment.
AP2005003432A0 (en) Novel method of treatment.
ZA985236B (en) Novel method of treatment.
ZA985235B (en) Novel method of treatment.
ZA985238B (en) Novel method of treatment.
ZA987316B (en) Method of treatment
GB9724289D0 (en) Method of treatment
ZA963472B (en) Method of treatment.
GB9703102D0 (en) Treatment method
EG24158A (en) Novel method of treatment
GB9824871D0 (en) Novel method of treatment
GB9824789D0 (en) Novel method of treatment
GB9824790D0 (en) Novel method of treatment
SI1135128T1 (sl) Nov postopek zdravljenja
GB9701448D0 (en) Methods of treatment